Radiol Imaging Cancer 2021 Sep;3(5):e200155
From the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Purpose To determine if amide proton transfer-weighted chemical exchange saturation transfer (APT CEST) MRI is useful in the early assessment of treatment response in persons with triple-negative breast cancer (TNBC). Materials and Methods In this prospective study, a total of 51 participants (mean age, 51 years [range, 26-79 years]) with TNBC were included who underwent APT CEST MRI with 0.9- and 2. Read More